Oxford Nanopore Technologies PLC (4R0.SG)
Chart Events
Performance Outlook
| Previous Close | 2.2560 |
| Open | 2.2360 |
| Bid | 2.1040 x N/A |
| Ask | 2.2120 x N/A |
| Day's Range | 2.1040 - 2.2360 |
| 52 Week Range | 1.9720 - 3.9200 |
| Volume | |
| Avg. Volume | 85 |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Subscribe to Yahoo Finance Plus to view Fair Value for 4R0.SG
Related Research
- PR Newswire
Bio-Techne and Oxford Nanopore Technologies partner to bring innovative reproductive health and carrier screening solutions to the market
Asuragen, a Bio-Techne brand (NASDAQ: TECH) and Oxford Nanopore Technologies plc (Oxford Nanopore) (LSE: ONT), today announce a collaboration to develop assays designed to deliver more accurate and reliable options for reproductive health and carrier screening. Asuragen will leverage its gold-standard PCR technology with Oxford Nanopore's any-read-length DNA sequencing capabilities to develop the first sequencing system to identify the most challenging yet high prevalence carrier genes in a sing
- ACCESSWIRE
ONT releases Remora: Most Comprehensive Methylation
By integrating Remora into MinKNOW the analysis of epigenetic modifications becomes seamless as it now runs in parallel to standard basecalling. This release complements the simplicity of native DNA sample preparation, which can be done in just 10 minutes using the same run, so at no additional cost.
- ACCESSWIRE
Oxford Nanopore Announces Tech Updates
With the latest updates, nanopore sequencing can now deliver very accurate, comprehensive data outputs, at high yields, with the ability to sequence short or long fragments, in real time and capture all variant types in one experiment, on one platform. Oxford Nanopore technology enables users to fit the technology to their biological question.
